O'Donnell F E, Santos B A, Overby J
O'Donnell Eye Institute, St. Louis, Missouri 63122, USA.
Ophthalmic Surg Lasers. 2000 Nov-Dec;31(6):508-11.
A phase I study of nonpenetrating trabeculectomy (Zimmerman procedure) using a scanning excimer laser system was conducted to evaluate the ability of this laser system to achieve the deep dissection required to allow significant filtration without inadvertent penetration into the anterior chamber. A photopolishing, scanning 193 nm excimer laser system (LS 2000, LaserSight, Inc.) was used with a proprietary fluence, spot size, scanning pattern, and ablation shape to perform a trabeculodissection under a scleral flap with a limbal-based conjunctival flap in 8 cases of advanced glaucoma including 5 eyes that had a failed trabeculectomy. The laser trabeculodissection (LTD) was carried through Schlemm's canal and the juxtacanalicular trabecular meshwork, achieving vigorous aqueous outflow. No peripheral iridectomy was done. The scleral flap was closed loosely with a 10-0 suture. Mitomycin-C was used intraoperatively. In no case did inadvertent penetration into the anterior chamber occur. No peripheral iridectomy was performed. No intraoperative hyphema occurred. There was no postoperative iritis except minimal anterior chamber reaction in 1 eye with preoperative rubeosis. Postoperatively, a good filtering bleb was achieved in all 8 eyes with substantial reduction in the intraocular pressure without topical antiglaucoma therapy. No cases of postoperative shallowing (overfiltration) occurred. Gonioscopy, postoperatively, revealed no new peripheral anterior synechiae (PAS) to the filtration site and an intact inner trabecular meshwork. All eyes were followed for a minimum of 6 months. In this phase I study, laser trabeculodissection (LTD) with a 193 nm photopolishing, scanning system appears to be a promising alternative to full-thickness trabeculectomy, achieving significant filtration while perhaps avoiding much of the risk of filtration surgery. The laser system seemed to provide a more reliable, better-controlled dissection than a knife. The aqueous drainage seems to have acted as a self-regulating endpoint by absorbing UV energy, thus avoiding inadvertent penetration into the anterior chamber. More study is needed to establish the appropriate role of LTD in glaucoma therapy.
开展了一项使用扫描准分子激光系统进行非穿透性小梁切除术(齐默尔曼手术)的I期研究,以评估该激光系统实现深度解剖的能力,这种深度解剖是实现显著滤过所必需的,同时避免意外穿透进入前房。使用了一种光抛光、扫描193nm准分子激光系统(LS 2000,LaserSight公司),其具有专利的能量密度、光斑大小、扫描模式和消融形状,对8例晚期青光眼患者(包括5例小梁切除术失败的眼睛)进行巩膜瓣下小梁切开术,巩膜瓣以角膜缘为基底,联合结膜瓣。激光小梁切开术(LTD)穿过施莱姆管和近管组织小梁网,实现了有力的房水流出。未进行周边虹膜切除术。用10-0缝线松散地缝合巩膜瓣。术中使用了丝裂霉素C。无一例发生意外穿透进入前房。未进行周边虹膜切除术。术中未发生前房积血。除1例术前有虹膜红变的眼睛出现轻微前房反应外,无术后虹膜炎发生。术后,所有8只眼睛均形成了良好的滤过泡,眼压显著降低,无需局部抗青光眼治疗。未发生术后浅前房(滤过过度)病例。术后房角镜检查显示,滤过部位未出现新的周边前粘连(PAS),内小梁网完整。所有眼睛至少随访6个月。在这项I期研究中,使用193nm光抛光扫描系统进行的激光小梁切开术(LTD)似乎是全层小梁切除术的一种有前景的替代方法,在实现显著滤过的同时,或许可避免滤过手术的许多风险。该激光系统似乎比手术刀提供了更可靠、更可控的解剖。房水引流似乎通过吸收紫外线能量起到了自我调节终点的作用,从而避免意外穿透进入前房。需要更多研究来确定LTD在青光眼治疗中的适当作用。